Blueprint Medicines Corp
BPMCDelisted Jul 18, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597264
Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2025 vs. Q1 2025
How the institutions holding Blueprint Medicines Corp changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 353 | 2 | 356 | +5 |
| Shares | 69.1M | 3.47K | 67.5M | −1.61M (−2.3%) |
| Value | $6.12B | $307.2K | $8.65B | +$2.54B (+41.5%) |
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (111)
Institutions that held Blueprint Medicines Corp at the end of Q2 2025 but not at the end of Q1 2025.
Showing the largest 100 of 111 by value.
Sold out (106)
Institutions that held Blueprint Medicines Corp at the end of Q1 2025 and filed for Q2 2025 without it.
Showing the largest 100 of 106 by value.
Not filed for Q2 2025 yet (2)
Institutions that held Blueprint Medicines Corp at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Glenmede Trust Co NA | 3,162 | $279.9K |
| Lindbrook Capital, LLC | 309 | $27.4K |